Loading...
NPI 1497017867 · Louisville, KY · Ophthalmology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Janelle Adeniran is a ophthalmology physician provider located in Louisville, Kentucky. This profile covers 17 Medicare and 2 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Janelle Adeniran |
| Address | 1935 Bluegrass Ave Ste 200 |
| City | Louisville |
| State | KY |
| ZIP | 40215 |
| Taxonomy | Ophthalmology Physician |
| NPI Enumerated | June 12, 2012 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.8M |
| Medicaid | $3.4K |
Practice profile and service mix: This NPI is an Ophthalmology Physician based in LOUISVILLE, KY, with billing concentrated in intravitreal medication administration and posterior-segment retinal services. High-volume Medicare codes include drug injections (J0178, J2777), retinal injections as a procedure (67028), and frequent retinal imaging (92134, 92250), consistent with a retina-focused clinical practice that manages medical retinal disease and delivers in-office injectable therapies.
Medicare revenue concentration: Total Medicare revenue is $1.8M and the top 3 Medicare codes by revenue account for 86.5% of that Medicare revenue. The two drug codes, J0178 ($1M revenue) and J2777 ($442K revenue), are the primary drivers of Medicare dollars, indicating heavy dependence on billed medication administration and associated procedural codes for revenue.
Medicaid revenue concentration and composition: Total Medicaid revenue is $3.4K and the precomputed top-3 Medicaid codes account for 100.0% of the provider's Medicaid revenue. Medicaid billing is concentrated in retinal diagnostic imaging (92134, $2.2K; 67.4% of Medicaid revenue) and established patient E/M visits (99214, $1.1K; 32.6% of Medicaid revenue), so Medicaid receipts are almost entirely imaging plus routine E/M services.
Payer mix and scale: This provider is effectively Medicare-dominant on volume and revenue, with $1.8M reported from Medicare versus $3.4K from Medicaid. The scale difference indicates the practice’s economics and contracting considerations will be driven overwhelmingly by Medicare reimbursement and drug-payment policies rather than Medicaid.
Competitive standing on major Medicare drug and procedure codes: For its top Medicare drug codes, J0178 ranks #815 of 3204 providers nationally (75th percentile; typical, unremarkable volume) and J2777 ranks #705 of 2039 providers nationally (65th percentile; typical, unremarkable volume), so the provider is a steady but not leading national participant in intravitreal drug administration. By contrast, several non-drug codes show unusually high relative volume — 99214 ranks in the 97th percentile and 92134 and 92250 rank in the 95th percentile — indicating the practice sees substantially more E/M and diagnostic imaging volume than most peers.
Operational implications for contracting and supply: With J0178 and J2777 as the top Medicare revenue drivers and a high share of revenue tied to injectable biologics, the practice is likely sensitive to drug acquisition costs, buy-and-bill arrangements, and site-of-care reimbursement rules. High utilization of retinal imaging (92134, 92250) and frequent established-patient visits (99214, 99213) also suggests stable follow-up workflows and ongoing monitoring needs that payers or partners should consider when structuring networks or bundled-payment arrangements.
Tenure and stability: The provider’s NPI was enumerated on 2012-06-12 (~14 years ago), indicating an established presence in the market. That tenure, combined with concentrated revenue streams in recurring injections and retinal diagnostics, suggests a stable, specialized clinical operation rather than a short-term or transient billing pattern.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
17 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 1,510 | $680 | $1M |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 15,240 | $30 | $442K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 1,230 | $90 | $104.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 860 | $80 | $70.3K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,800 | $30 | $48.5K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 750 | $60 | $45.2K |
| 67036 | The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana. | 30 | $640 | $16.7K |
| J3590 | Unclassified biologics | 290 | $50 | $14.1K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 140 | $100 | $14.1K |
| 67228 | In retinopathy, tiny new vessels grow profusely and fibrous tissue proliferates in between the layers of the retina, which may extend into the optic nerve and vitreous, clear gel that fills the space… | 50 | $250 | $11.4K |
Showing 1–10 of 17
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
17 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J0178 | 16 | 40 | 870 | $690 | $858.5K |
| J2777 | 8 | 30 | 11,040 | $30 | $399.1K |
| 67028 | 17 | 50 | 650 | $90 | $72.9K |
| 67036 | 8 | 20 | 20 | $910 | $28.1K |
| J3590 | 12 | 40 | 160 | $60 | $17K |
| 99214 | 154 | 7,230 | 110 | $70 | $14.1K |
| 99213 | 141 | 7,250 | 80 | $50 | $7.7K |
| 67228 | 2 | 10 | 30 | $230 | $6.6K |
| 92134 | 17 | 410 | 50 | $30 | $6.3K |
| 92235 | 5 | 20 | 30 | $90 | $5.3K |
Showing 1–10 of 17
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
2 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 70 | $30 | $2.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 20 | $60 | $1.1K |
How this provider's Medicaid billing volume and revenue compare to other Kentucky providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Kentucky median
2 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 2,284 | 2,460 | 580 | $40 | $245K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 51 | 70 | 210 | $20 | $29.2K |
Other providers in the same ZIP code as Janelle Adeniran, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Landmark Recovery Of Kentucky LLC | KY | Substance Abuse Rehabilitation Facility | $0 | $21.1M |
| Behavior Analysts Of Texas, LLC | KY | Behavior Analyst | $0 | $13.1M |
| Vip Imaging, PLLC | KY | Diagnostic Radiology Physician | $0 | $5.3M |
| Steven Bloom | KY | Ophthalmology Physician | $2.3M | $232K |
| Lewis Hargett | KY | Physical Medicine & Rehabilitation Physician | $103.6K | $685.6K |
| Denise Dickinson | KY | Dermatology Physician | $632.7K | $0 |
| John Millin | KY | Ophthalmology Physician | $457.5K | $43.5K |
| Adam Mueller | KY | Optometrist | $141.5K | $277.7K |
| Lawrence Tenkman | KY | Ophthalmology Physician | $383.7K | $0 |
| Nikolaos Zagorianos | KY | Optometrist | $283.5K | $3.3K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.